Who is sponsoring NCT00298610?

NCT00298610 is sponsored by U.S. Army Medical Research and Development Command.

What drugs are being tested in NCT00298610?

Interventions: Artesunate, Malarone.

What is the status of NCT00298610?

NCT00298610 is currently COMPLETED.

Last reviewed 2019-09-20 · How we verify

A Phase II, Open Label, Study of the Safety, Tolerability, Efficacy and Pharmacokinetics of Intravenous Artesunate in Adults With Uncomplicated Malaria

NCT00298610 Phase 2 COMPLETED Results posted

The purpose of this study is to determine how GMP IV Artesunate is metabolized and cleared by individuals with uncomplicated malaria infection and to determine how fast it eliminates malaria infection from the body.

Details

Lead sponsor	U.S. Army Medical Research and Development Command
Phase	Phase 2
Status	COMPLETED
Enrolment	30
Start date	2006-03
Completion	2007-10

Conditions

Malaria

Interventions

Artesunate
Malarone

Primary outcomes

Change in Percentage of Parasites Detected at 48 Hours — 48 hours
Change in Percentage of Parasites Detected at 48 Hours. With positive numbers to represent increases and negative numbers to represent decreases

Countries

Kenya